Literature DB >> 1985290

Mesencephalic cholinergic nuclei in progressive supranuclear palsy.

J L Juncos1, E C Hirsch, S Malessa, C Duyckaerts, L B Hersh, Y Agid.   

Abstract

Using an antibody against choline acetyltransferase (ChAT), mesencephalic cholinergic cell nuclei were studied in autopsy material from 3 cases of progressive supranuclear palsy (PSP) and 4 controls. ChAT-immunoreactive neurons were quantified in sections that spanned the rostrocaudal extent of each nucleus. In PSP, there was a significant decrease in the number of neurons with detectable immunoreactivity for ChAT in and adjacent to the central gray substance in the following nuclei: the nucleus of Edinger-Westphal (69%); the rostral interstitial nucleus of the medial longitudinal fasciculus (97%); the interstitial nucleus of Cajal (78%). A cell loss was also evident in a group of neurons found in the deep layers of the superior colliculus (93%). In contrast, the estimated number of ChAT-immunoreactive cell bodies in cranial nerves III and IV, in the mesencephalic reticular formation, and in the parabigeminal nucleus was not different from that of controls. The results are compatible with the notion that, in PSP, there is a regionally selective destruction of cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985290     DOI: 10.1212/wnl.41.1.25

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Progressive supranuclear palsy (Steele-Richardson-Olszewski disease).

Authors:  H R Morris; N W Wood; A J Lees
Journal:  Postgrad Med J       Date:  1999-10       Impact factor: 2.401

2.  Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus.

Authors:  Phil Hyu Lee; Suk Woo Yong; Young Hwan Ahn; Kyoon Huh
Journal:  J Neurol       Date:  2005-04-19       Impact factor: 4.849

3.  Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism.

Authors:  G K Wenning; K Jellinger; I Litvan
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Differential cholinergic systems' changes in progressive supranuclear palsy versus Parkinson's disease: an exploratory analysis.

Authors:  Prabesh Kanel; C Chauncey Spears; Stiven Roytman; Robert A Koeppe; Kirk A Frey; Peter J H Scott; Roger L Albin; Nicolaas I Bohnen
Journal:  J Neural Transm (Vienna)       Date:  2022-10-12       Impact factor: 3.850

5.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

6.  The auditory startle response in parkinsonism may reveal the extent but not type of pathology.

Authors:  David R Williams; Louise M F Doyle; Andrew J Lees; Peter Brown
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

7.  Midbrain atrophy in subcortical ischemic vascular dementia.

Authors:  Young-Hee Sung; Ki-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Jea-Sul Park; Mi-Sun Oh; Hyeo-Il Ma; Kyung-Ho Yu; Suk-Yun Kang; Yun Joong Kim; Byung-Chul Lee
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

8.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

9.  Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow.

Authors:  Aasef G Shaikh; Stewart A Factor; Jorge Juncos
Journal:  Mov Disord Clin Pract       Date:  2017-08-11

10.  Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.

Authors:  Tao Xie; Un J Kang; Sheng-Han Kuo; Markos Poulopoulos; Paul Greene; Stanley Fahn
Journal:  NPJ Parkinsons Dis       Date:  2015-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.